Other effects include m6A modifications (27), glycolysis-associated lncRNA of colorectal cancer (GLCC1) (28), and insulin-like growth factor 1 (IGF-1) signaling (29), which could also enhance glycolysis in different paths. Here, FARP1 is linked to colorectal cancer.